^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    KDR rs1870377

    i
    Other names: KDR, CD309, FLK1, VEGFR, VEGFR2, Kinase insert domain receptor (a type III receptor tyrosine kinase)
    Entrez ID:
    3791
    Related biomarkers:
    Expression
    Mutation
    CNA
    Others
    over1year
    A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Topical Urea for Secondary Prophylaxis of Hand Foot Skin Reaction in Renal Cell Cancer Patients on Sunitinib Therapy. (PubMed, Clin Genitourin Cancer)
    The study suggested that the urea-based cream was not superior to placebo in decreasing the appearance of new HFSR in renal cancer patients receiving 4:2 regimen of sunitinib.
    Clinical • Journal
    |
    KDR (Kinase insert domain receptor)
    |
    KDR rs1870377
    |
    sunitinib
    2years
    Association of KDR (rs2071559, rs1870377), CFH (rs1061170, rs1410996) genes variants and serum levels with pituitary adenoma. (PubMed, Mol Genet Genomic Med)
    KDR rs2071559, rs1870377, and CFH rs1061170 could be potential biomarkers associated with PA.
    Journal
    |
    KDR (Kinase insert domain receptor)
    |
    KDR rs1870377